Terazosin Modifies the Content of Glycosaminoglycans and the Activity of Matrix Metalloproteinase 2 in the Rat Ventral Prostate

European Urology

Volumn 51, Issue 2, 2007, Pages 447-456

  Mitropoulos, Dionisios ^a   Papakonstantinou, Eleni ^b   Aletras, Alexios J ^c   Kalinderis, Nikolaos ^b   Zervas, Anastasios ^a   Hatzichristou, Dimitrios ^b   Karakiulakis, George ^b  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^c UNIVERSITY OF PATRAS   (Greece)

Author keywords

Adrenoreceptor antagonists; Glycosaminoglycans; Matrix metalloproteinases; Prostate; Rat; Terazosin

Indexed keywords

ALCOHOL; CHONDROITIN SULFATE; DEOXYRIBONUCLEASE; DERMATAN SULFATE; GELATINASE A; GELATINASE B; GLYCOSAMINOGLYCAN; HEPARAN SULFATE; HYALURONIC ACID; LIPID; PRONASE; TERAZOSIN; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2;

ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; ELECTROPHORESIS; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; EXTRACTION; MALE; NONHUMAN; ORGAN WEIGHT; PRECIPITATION; PRIORITY JOURNAL; PROSTATE VENTRAL LOBE; RAT; ZYMOGRAPHY;

ADRENERGIC ALPHA-ANTAGONISTS; ANIMALS; GLYCOSAMINOGLYCANS; MALE; MATRIX METALLOPROTEINASE 2; PRAZOSIN; PROSTATE; RATS; RATS, WISTAR;

EID: 33845575267     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eururo.2006.06.028     Document Type: Article

References (47)

1. Udayakumar T.S., Jeyaraj D.A., Rajalakshmi M., and Sharma R.S. Culture of prostate epithelial cells of the rhesus monkey on extracellular matrix substrate: influence of steroids and insulin-like growth factors. J Endocrinol 162 (1999) 443-450
2. Kassen A.E., Sensibar J.A., Sintich S.M., Pruden S.J., Kozlowski J.M., and Lee C. Autocrine effect of DHT on FGF signaling and cell proliferation in LNCaP cells: role of heparin/heparan-degrading enzymes. Prostate 44 (2000) 124-132
3. McConnell J.D. Epidemiology, etiology, pathophysiology and diagnosis of benign prostatic hyperplasia. In: Walsh P.C., Wein A.J., Retik A.B., and Vaughan E.D. (Eds). Campbell's urology. 7th ed. (1998), Saunders, Philadelphia 1429-1452
4. Nishimura M., Yan W., Mukudai Y., et al. Role of chondroitin sulfate-hyaluronan interactions in the viscoelastic properties of extracellular matrices and fluids. Biochim Biophys Acta 1380 (1998) 1-9
5. Papakonstantinou E., Karakiulakis G., Eickelberg O., Perruchoud A.P., and Block L.H. Roth M. A 340 kDa hyaluronic acid secreted by human vascular smooth muscle cells regulates their proliferation and migration. Glycobiology 8 (1998) 821-830
6. Papakonstantinou E., Roth M., Block L.H., Mirtsou-Fidani V., Argiriadis P., and Karakiulakis G. The differential distribution of hyaluronic acid in the layers of human atheromatic aortas is associated with vascular smooth muscle cell proliferation and migration. Atherosclerosis 138 (1998) 79-89
7. Mogyorosi A., and Ziyadeh F.N. Increased decorin mRNA in diabetic mouse kidney and in mesangial and tubular cells cultured in high glucose. Am J Physiol 275 (1998) F827-F832
8. Terry D.E., and Clark A.F. Glycosaminoglycans in the three lobes of the rat prostate following castration and testosterone treatment. Biochem Cell Biol 74 (1996) 653-658
9. Passi A., Albertini R., Campagnari F., and De Luca G. Modifications of proteoglycans secreted into the growth medium by young and senescent human skin fibroblasts. FEBS Lett 402 (1997) 286-290
10. De Klerk D.P. The glycosaminoglycans of normal and hyperplastic prostate. Prostate 4 (1983) 73-81
11. Iida S., Suzuki K., Matsuoka K., et al. Analysis of glycosaminoglycans in human prostate by high-performance liquid chromatography. Br J Urol 79 (1997) 763-769
12. Cardoso L.E., Falcao P.G., and Sampaio F.J. Increased and localized accumulation of chondroitin sulphate proteoglycans in the hyperplastic human prostate. BJU Int 93 (2004) 532-538
13. Goulas A., Hatzichristou D.G., Karakiulakis G., Mirtsou-Fidani V., Kalinderis A., and Papakonstantinou E. Benign hyperplasia of the human prostate is associated with tissue enrichment in chondroitin sulphate of wide size distribution. Prostate 44 (2000) 104-110
14. Visse R., and Nagase H. Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circ Res 92 (2003) 827-839
15. Gomez D.E., Alonso D.F., Yoshiji H., and Thorgeirsson U.P. Tissue inhibitors of metalloproteinases: structure, regulation and biological functions. Eur J Cell Biol 74 (1997) 111-122
16. Wilson M.J., Garcia B., Woodson M., and Sinha A.A. Metalloproteinase activities expressed during development and maturation of the rat prostatic complex and seminal vesicles. Biol Reprod 47 (1992) 683-691
17. Wilson M.J., Norris H., Kapoor D., Woodson M., Limas C., and Sinha A.A. Gelatinolytic and caseinolytic proteinase activities in human prostatic secretions. J Urol 149 (1993) 653-658
18. Wilson M.J., Sellers R.G., Wiehr C., Melamud O., Pei D., and Peehl D.M. Expression of matrix metalloproteinase-2 and -9 and their inhibitors, tissue inhibitor of metalloproteinase-1 and -2, in primary cultures of human prostatic stromal and epithelial cells. J Cell Physiol 191 (2002) 208-216
19. Caine M., Pfau A., and Perlberg S. The use of alpha-adrenergic blockers in benign prostatic obstruction. Br J Urol 48 (1976) 255-263
20. Chon J.K., Borkowski A., Partin A.W., Isaacs J.T., Jacobs S.C., and Kyprianou N. Alpha 1-adrenoceptor antagonists terazosin and doxazosin induce prostate apoptosis without affecting cell proliferation in patients with benign prostatic hyperplasia. J Urol 161 (1999) 2002-2008
21. Madersbacher S., Alivizatos G., Nordling J., Sanz C.R., Emberton M., and de la Rosette J.J. EAU 2004 guidelines on assessment, therapy and follow-up of men with lower urinary tract symptoms suggestive of benign prostatic obstruction (BPH guidelines). Eur Urol 46 (2004) 547-554
22. McNeill S.A. The role of alpha-blockers in the management of acute urinary retention caused by benign prostatic obstruction. Eur Urol 45 (2004) 325-332
23. 1-adrenoceptor antagonists for the treatment of lower urinary tract symptoms suggestive of benign prostatic hyperplasia (LUTS/BPH): state of the art. Eur Urol Suppl 3 4 (2004) 23-30
24. Kyprianou N. Doxazosin and terazosin suppress prostate growth by inducing apoptosis: clinical significance. J Urol 169 (2003) 1520-1525
25. Tahmatzopoulos A., and Kyprianou N. Apoptotic impact of alpha1-blockers on prostate cancer growth: a myth or an inviting reality?. Prostate 59 (2004) 91-100
26. Papakonstantinou E., Karakiulakis G., Roth M., and Block L.H. Platelet-derived growth factor stimulates the secretion of hyaluronic acid by proliferating human vascular smooth muscle cells. Proc Natl Acad Sci USA 92 (1995) 9881-9885
27. Bitter T., and Muir H.M. A modified uronic acid carbazole reaction. Anal Biochem 4 (1962) 330-334
28. Papakonstantinou E., Karakiulakis G., Tamm M., Perruchoud A.P., and Roth M. Hypoxia modifies the effect of PDGF on glycosaminoglycan synthesis by primary human lung cells. Am J Physiol Lung Cell Mol Physiol 279 (2000) L825-L834
29. Papakonstantinou E., and Misevic G.N. Isolation and characterization of a new class of acidic glycans implicated in sea urchin embryonal cell adhesion. J Cell Biochem 53 (1993) 98-113
30. Karakiulakis G., Missirlis E., Aletras A., and Maragoudakis M.E. Degradation of intact basement membranes by human and murine tumor enzymes. Biochim Biophys Acta 967 (1988) 163-175
31. Karakiulakis G., Papanikolaou C., Jankovic S.M., et al. Increased type IV collagen-degrading activity in metastases originating from primary tumors of the human colon. Invasion Metastasis 17 (1997) 158-168
32. Papakonstantinou E., Dionyssopoulos A., Aletras A.J., Pesintzaki C., Minas A., and Karakiulakis G. Expression of matrix metalloproteinases and their endogenous tissue inhibitors in skin lesions from patients with tuberous sclerosis. J Am Acad Dermatol 51 (2004) 526-533
33. Papakonstantinou E., Aletras A.J., Roth M., Tamm M., and Karakiulakis G. Hypoxia modulates the effects of transforming growth factor-beta isoforms on matrix-formation by primary human lung fibroblasts. Cytokine 24 (2003) 25-35
34. Lujan M., Paez A., Llanes L., Angulo J., and Berenguer A. Role of autonomic innervation in rat prostatic structure maintenance: a morphometric analysis. J Urol 160 (1998) 1919-1923
35. Yang G., Timme T.L., Park S.H., Wu X., Wyllie M.G., and Thompson T.C. Transforming growth factor beta 1 transduced mouse prostate reconstitutions. II. Induction of apoptosis by doxazosin. Prostate 33 (1997) 157-163
36. Rollins B.J., and Culp L.A. Glycosaminoglycans in the substrate adhesion sites of normal and virus-transformed murine cells. Biochemistry 18 (1979) 141-148
37. Weber G.F., Ashkar S., Glimcher M.J., and Cantor H. Receptor-ligand interaction between CD44 and osteopontin (Eta-1). Science 271 (1996) 509-512
38. Cartel N.J., and Post M. Abrogation of apoptosis through PDGF-BB-induced sulfated glycosaminoglycan synthesis and secretion. Am J Physiol Lung Cell Mol Physiol 288 (2005) L285-L293
39. Simonaro C.M., Haskins M.E., and Schuchman E.H. Articular chondrocytes from animals with a dermatan sulfate storage disease undergo a high rate of apoptosis and release nitric oxide and inflammatory cytokines: a possible mechanism underlying degenerative joint disease in the mucopolysaccharidoses. Lab Invest 81 (2001) 1319-1328
40. Jung K., Krell H.W., Ortel B., et al. Plasma matrix metalloproteinase 9 as biomarker of prostate cancer progression in Dunning (Copenhagen) rats. Prostate 54 (2003) 206-211
41. Upadhyay J., Shekarriz B., Nemeth J.A., et al. Membrane type 1-matrix metalloproteinase (MT1-MMP) and MMP-2 immunolocalization in human prostate: change in cellular localization associated with high-grade prostatic intraepithelial neoplasia. Clin Cancer Res 5 (1999) 4105-4110
42. Still K., Robson C.N., Autzen P., Robinson M.C., and Hamdy F.C. Localization and quantification of mRNA for matrix metalloproteinase-2 (MMP-2) and tissue inhibitor of matrix metalloproteinase-2 (TIMP-2) in human benign and malignant prostatic tissue. Prostate 42 (2000) 18-25
43. Menon B., Singh M., and Singh K. Matrix metalloproteinases mediate beta-adrenergic receptor-stimulated apoptosis in adult rat ventricular myocytes. Am J Physiol Cell Physiol 289 (2005) C168-C176
44. Ben-Yosef Y., Miller A., Shapiro S., and Lahat N. Hypoxia of endothelial cells leads to MMP-2-dependent survival and death. Am J Physiol Cell Physiol 289 (2005) C1321-C1331
45. Pereira A.M., Strasberg-Rieber M., and Rieber M. Invasion-associated MMP-2 and MMP-9 are up-regulated intracellularly in concert with apoptosis linked to melanoma cell detachment. Clin Exp Metastasis 22 (2005) 285-295
46. Zhou X., Li F., Kong L., Tomita H., Li C., and Cao W. Involvement of inflammation, degradation, and apoptosis in a mouse model of glaucoma. J Biol Chem 280 (2005) 31240-31248
47. Taketani T., Imai Y., Morota T., et al. Altered patterns of gene expression specific to thoracic aortic aneurysms: microarray analysis of surgically resected specimens. Int Heart J 46 (2005) 265-277